The formation of Eliglustat impurities is minimized by optimizing reaction conditions, employing suitable purification techniques, ensuring proper storage and handling, and conducting stability studies to understand degradation pathways.

Impurities in Eliglustat can potentially impact its efficacy by altering the drug's pharmacokinetics, stability, or interaction with the target receptors. Hence, their control is essential to maintain the desired therapeutic effect.

Analyzing Eliglustat impurities can be challenging due to their low concentrations, potential complexity, and the need for sensitive and specific analytical techniques. Validation of analytical methods is crucial for accurate impurity detection.

Eliglustat impurities are stored at a controlled room temperature, 2-8 °C, or under a Nitrogen atmosphere. You can refer to the storage on the Certificate of Analysis (CoA) specifications.